期刊文献+

接枝的同类的现象当在生活施主肝移植使用接受者 / 施主特征的不同遗传型时 被引量:1

Homogeneous phenomenon of the graft when using different genotype characteristic of recipients/donors in living donor liver transplantation
下载PDF
导出
摘要 AIM:To investigate the evidence of homogeneous phenomenon on CYP3A5*3 MDR1-3435 and CYP3A4*18of the liver graft after living donor liver transplantation(LDLT).METHODS:We identified the proportional change of the CYP3A5*3,MDR1-3435 and CYP3A4*18 from the peripheral blood mononuclear cell of 41 pairs recipient/donor with different genotype polymorphisms and 119liver graft biopsy samples used with the pyrosequencing technique after LDLT.Polymerase chain reaction/ligase detection reaction assay and restriction fragment length polymorphism was employed for genotyping the CYP3A5*3 and CYP3A4*18 single nucleotide poly-morphisms(SNPs).All of the recipients and donors expressed with the similar SNP genotype of CYP3A5*3,MDR1-3435 or CYP3A4*18 were excluded.RESULTS:The final genetic polymorphisms of the liver graft biopsy samples of CYP3A5*3,MDR1-3435 and CYP3A4*18 was predominated depends on the donor with restriction fragment length polymorphism and seems to be less related to the recipient.The proportional changes of G to A alleles of the 119 samples of CYP3A5*3(included A】A/G,A/G】A,A/G】G,G】A,G】A/G and A】G),C to T alleles of the 108 samples of MDR1-3435(included C】C/T,C/T】C,C/T】T,T】C/T and T】C),and T to C alleles of 15 samples of CYP3A4*18(included T/C】T and T】C/T)were significant different between the recipients and the liver graft biopsy samples(P【0.0001)and less difference when compared with the donors in the pyrosequencing analysis after LDLT.CONCLUSION:The CYP3A5*3,MDR1-3435 and CYP3A4*18 of the recipient could be modified by the donor so-called homogenous phenomenon when the recipient’s blood drained into the liver graft. AIM:To investigate the evidence of homogeneous phenomenon on CYP3A5*3 MDR1-3435 and CYP3A4*18of the liver graft after living donor liver transplantation(LDLT).METHODS:We identified the proportional change of the CYP3A5*3,MDR1-3435 and CYP3A4*18 from the peripheral blood mononuclear cell of 41 pairs recipient/donor with different genotype polymorphisms and 119liver graft biopsy samples used with the pyrosequencing technique after LDLT.Polymerase chain reaction/ligase detection reaction assay and restriction fragment length polymorphism was employed for genotyping the CYP3A5*3 and CYP3A4*18 single nucleotide poly-morphisms(SNPs).All of the recipients and donors expressed with the similar SNP genotype of CYP3A5*3,MDR1-3435 or CYP3A4*18 were excluded.RESULTS:The final genetic polymorphisms of the liver graft biopsy samples of CYP3A5*3,MDR1-3435 and CYP3A4*18 was predominated depends on the donor with restriction fragment length polymorphism and seems to be less related to the recipient.The proportional changes of G to A alleles of the 119 samples of CYP3A5*3(included A>A/G,A/G>A,A/G>G,G>A,G>A/G and A>G),C to T alleles of the 108 samples of MDR1-3435(included C>C/T,C/T>C,C/T>T,T>C/T and T>C),and T to C alleles of 15 samples of CYP3A4*18(included T/C>T and T>C/T)were significant different between the recipients and the liver graft biopsy samples(P<0.0001)and less difference when compared with the donors in the pyrosequencing analysis after LDLT.CONCLUSION:The CYP3A5*3,MDR1-3435 and CYP3A4*18 of the recipient could be modified by the donor so-called homogenous phenomenon when the recipient’s blood drained into the liver graft.
出处 《World Journal of Hepatology》 CAS 2013年第11期642-648,共7页 世界肝病学杂志(英文版)(电子版)
基金 Supported by A grant from Chang Gung Memorial Hospital,CMRPG8A0631 to Chiu KW of Taiwan
关键词 PYROSEQUENCING CYP3A5*3 MDR1-3435 CYP3A4*18 LIVER biopsy Living donor LIVER transplantation Pyrosequencing CYP3A5*3 MDR1-3435 CYP3A4*18 Liver biopsy Living donor liver transplantation
  • 相关文献

参考文献25

  • 1S. Brückner,H.-M. Tautenhahn,S. Winkler,P. Stock,S. Jonas,M. Dollinger,B. Christ.Isolation and Hepatocyte Differentiation of Mesenchymal Stem Cells From Porcine Bone Marrow—“Surgical Waste” as a Novel MSC Source[J]. Transplantation Proceedings . 2013 (5)
  • 2King‐WahChiu,ToshiakiNakano,Tsung‐HuiHu,Hui‐PengTseng,Yu‐FanCheng,BrunoJawan,Hock‐LiewEng,ShigeruGoto,Chao‐LongChen.Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation[J]. European Journal of Clinical Investigation . 2012 (4)
  • 3King‐WahChiu,Wei‐ChenTai,ToshiakiNakano,Hui‐PengTseng,Yu‐FanCheng,BrunoJawan,ShigeruGoto,Chao‐LongChen.Donor graft does not affect the P450 2C19 genotype expressed in peripheral blood in recipients of living donor liver transplantation[J]. Clinical Transplantation . 2010 (6)
  • 4Barbara Gawrońska-Szklarz,Andrzej Siuda,Mateusz Kurzawski,Dariusz Bielicki,Wojciech Marlicz,Marek Dro?dzik.Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole[J]. European Journal of Clinical Pharmacology . 2010 (7)
  • 5Solveig Eriksson,Lars M Berg,Mia Wadelius,Anders Alderborn.Cytochrome P450 Genotyping by Multiplexed Real-Time DNA Sequencing with Pyrosequencing? Technology. ASSAY and Drug Development Technologies . 2002
  • 6Hiroshi Yamazaki,Ayaka Shibata,Mikie Suzuki,Miki Nakajima,Noriaki Shimada,F. Peter Guengerich,Tsuyoshi Yok.Oxidation of Troglitazone to a Quinone-Type Metabolite Catalyzed by Cytochrome P-450 2C8 and P-450 3A4 in Human Liver Microsomes. Drug Metabolism and Disposition . 1999
  • 7Peter Kuehl,Jiong Zhang,Yvonne Lin,Jatinder Lamba,Mahfoud Assem,John Schuetz,Paul B. Watkins,Ann Daly,Steven A. Wrighton,Stephen D. Hall,Patrick Maurel,Mary Relling,Cynthia Brimer,Kazuto Yasuda,Raman Venkataramanan,Stephen Strom,Kenneth Th.Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nature Genetics . 2001
  • 8Crettol Séverine,Venetz Jean-Pierre,Fontana Massimiliano,Aubert John-David,Pascual Manuel,Eap Chin B.CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients. Therapeutic Drug Monitoring . 2008
  • 9Qiu XY,Jiao Z,Zhang M, et al.Association of MDR1, CYP3A4*18B, andCYP3A5*3polymorphisms with cyclosporine pharmacokinetics in Chinese renaltransplant recipients. European Journal of Clinical Pharmacology . 2008
  • 10Chiu KW,Hu TH,Nakano T,et al.Biological interactions of CYP2C19 genotypes with CYP3A4*18,CYP3A5*3,and MDR1-3435 in living donor liver transplantation recipients. Transplant Res . 2013

同被引文献4

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部